Dynavax Technologies Corporation, a biopharmaceutical company known for its innovative vaccines, has received a recommendation from Institutional Shareholder Services (ISS), a leading independent proxy advisory firm, urging stockholders to vote "FOR" all four of the company's director nominees in the upcoming Annual Meeting of Stockholders scheduled for June 11, 2025. The nominees include Brent MacGregor, Scott Myers, Lauren Silvernail, and Elaine Sun. ISS has recognized Dynavax's current board as being best equipped to deliver long-term stockholder value, countering a campaign by Deep Track, which ISS claims could harm long-term value. Dynavax has emphasized the importance of each vote and is encouraging stockholders to use the GOLD proxy card to support the recommended nominees. The company has enlisted Goldman Sachs & Co. LLC as its financial advisor and Cooley LLP as legal counsel.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.